Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2024-05-23 AGM Information
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA - Annual general meeting held
AGM Information Classification · 100% confidence The document text explicitly contains the heading "PROTOKOLL FRA ORDINÆR GENERALFORSAMLING" (Minutes from Annual General Meeting) in both Norwegian and English. It details the proceedings, resolutions passed (like approval of annual accounts, remuneration for board members, and election of directors), and the date of the meeting (May 23, 2024). This content is characteristic of the official record of an Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information).
2024-05-23 English
Photocure ASA - Annual general meeting held
AGM Information Classification · 98% confidence The document explicitly states it concerns the 'Annual general meeting held' by Photocure ASA on May 23, 2024. It mentions that the 'minutes from the general meeting setting out the resolutions are attached hereto.' This content directly relates to the proceedings and outcomes of the AGM. Although it mentions minutes are attached, the primary subject is the AGM event itself, making 'AGM Information' (AGM-R) the most appropriate classification, as it contains information about the meeting that took place.
2024-05-23 English
Photocure ASA - Annual general meeting held
AGM Information Classification · 98% confidence The document explicitly states it concerns the 'Annual general meeting held' by Photocure ASA on May 23, 2024. It mentions that the 'minutes from the general meeting setting out the resolutions are attached hereto.' Since this document is very short (1071 chars) and serves primarily to announce the meeting occurred and that the resolutions/minutes are attached, it fits the definition of AGM Information (AGM-R) rather than a full regulatory filing or a proxy statement. It is the announcement/record of the AGM.
2024-05-23 English
Photocure ASA: Results for the first quarter of 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Report Q1 2024' and contains detailed financial statements, operational reviews, and management commentary for the first quarter of 2024. It provides specific financial data (revenue, EBITDA, EBIT, etc.) and compares it to the previous year's corresponding period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-15 English
Photocure ASA: Results for the first quarter of 2024
Investor Presentation Classification · 99% confidence The document is explicitly titled "Photocure ASA 1st Quarter 2024 Results" and contains detailed financial tables for Q1 '24 vs Q1 '23, including Consolidated Income Statement and Segment Performance breakdowns. This structure, focusing on a specific, shorter reporting period (quarterly), clearly identifies it as a comprehensive financial report for that period, rather than just an initial earnings release (ER) or a general presentation (IP). Since it is a comprehensive report for a period shorter than a year, the appropriate classification is Interim / Quarterly Report (IR). The document is substantial (19,375 chars) and contains the full results, not just an announcement of the results.
2024-05-15 English
Photocure ASA: Results for the first quarter of 2024
Earnings Release Classification · 100% confidence The document explicitly states it contains "Results for the first quarter of 2024" and provides detailed financial metrics (revenues, EBITDA, EBIT) for that period, along with reiterating financial guidance for the full year 2024. This content structure is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it presents the key results and highlights immediately, it fits the definition of an Earnings Release (ER). Although it mentions the full financial report and presentation are enclosed/will be published, the primary content provided here is the summary announcement of the quarterly results, making ER the most appropriate classification over IR (which is usually the comprehensive document itself) or RPA (which is just an announcement *about* the report). The document length (6011 chars) is substantial enough to be the release itself, not just a brief announcement wrapper. Q1 2024
2024-05-15 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.